↓ Skip to main content

A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, March 2021
Altmetric Badge

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis
Published in
Arthritis Research & Therapy, March 2021
DOI 10.1186/s13075-021-02468-0
Pubmed ID
Authors

Kathleen Weisel, Scott Berger, Katie Thorn, Peter C. Taylor, Charles Peterfy, Hilary Siddall, Debra Tompson, Susanne Wang, Emilia Quattrocchi, Susan W. Burriss, Jochen Walter, Paul Peter Tak

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 22%
Researcher 7 13%
Student > Bachelor 5 9%
Student > Master 4 7%
Student > Doctoral Student 2 4%
Other 3 5%
Unknown 22 40%
Readers by discipline Count As %
Medicine and Dentistry 10 18%
Biochemistry, Genetics and Molecular Biology 8 15%
Pharmacology, Toxicology and Pharmaceutical Science 6 11%
Immunology and Microbiology 5 9%
Agricultural and Biological Sciences 2 4%
Other 3 5%
Unknown 21 38%